References
- Barrette RW, SA Metwally, JM Rowland, L Xu, SR Zaki, ST Nichol, P, et al. Discovery of swine as a host for the Reston ebolavirus. Science. 2009, 325(5937): 204-206. https://doi.org/10.1126/science.1172705
- Bausch DG, JS Towner, SF Dowell, F Kaducu, M. Lukwiya, A Sanchez, et al.. Assessment of the risk of Ebola virus transmission from bodily fluids and fomites. Journal of Infectious Diseases. 2007, 196(Supplement 2): S142-S147. https://doi.org/10.1086/520545
- Bwaka MA, M.J Bonnet, P Calain, R Colebunders, A De Roo, Y Guimard, et al. Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. Journal of Infectious Diseases. 1999, 179(Supplement 1): S1-S7. https://doi.org/10.1086/514308
- Dixon MG, IJ Schafer. Ebola viral disease outbreak-West Africa, 2014. MMWR Morb Mortal Wkly Rep 2014, 63(25):548-551.
- Feldmann H, TW Geisbert. Ebola haemorrhagic fever. The Lancet. 2001, 377(9768): 849-862.
- Feldmann H, HD Klenk. Marburg and Ebola viruses. Advances in Virus Research. 1996, 47: 1-52.
- Formenty P, C Hatz, B Le Guenno, A Stoll, P Rogenmoser, A Widmer. Human infection due to Ebola virus, subtype Cote d'Ivoire: clinical and biologic presentation. Journal of Infectious Diseases. 1999, 179(Supplement 1): S48-S53. https://doi.org/10.1086/514285
- Francesconi P, Z Yoti, S Declich, PA Onek, M Fabiani, J Olango, et al. Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda. Emerging Infectious Diseases. 2003, 9(11):1430. https://doi.org/10.3201/eid0911.030339
- Geisbert TW, ACH Lee, M. Robbins, JB Geisbert, AN Honko, V Sood, et al.. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study. The Lancet. 2010, 375(9729): 1896-1905. https://doi.org/10.1016/S0140-6736(10)60357-1
- Grolla A, A Lucht, D Dick, JE Stron, H Feldmann. Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull Soc Pathol Exot. 2005, 98(3): 205.
- J Alimonti, A Leung, S Jones, J Gren, X Qiu, L Fernando, et al. Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Scientific Reports 4. 2014, doi:10.1038/srep05824.
- Jahrling PB, TW Geisbert, ED Johnson, CJ Peters, D Dalgard, W. Hall. Preliminary report: isolation of Ebola virus from monkeys imported to USA. The Lancet. 1990, 335(8688): 502-505. https://doi.org/10.1016/0140-6736(90)90737-P
- Kanapathipillai R, AM Henao Restrepo, P Fast, D Wood, C Dye, M.P Kieny, et al. Ebola vaccine-an urgent international priority. New England Journal of Medicine. 2014, 371(24): 2249-2251. https://doi.org/10.1056/NEJMp1412166
- Kilgore PE, JD Grabenstein, AM Salim, M. Rybak. Treatment of ebola virus disease. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2015, 35(1): 43-53. https://doi.org/10.1002/phar.1545
- Kortepeter MG, DG Bausch, M Bray. "Basic clinical and laboratory features of filoviral hemorrhagic fever." Journal of Infectious Diseases. 2011, 204(suppl 3): S810-S816. https://doi.org/10.1093/infdis/jir299
- Leroy EM, S Baize, CY Lu, J McCormick, A Georges, M Georges-Courbot, et al. Diagnosis of Ebola haemorrhagic fever by RTPCR in an epidemic setting. Journal of Medical Virology. 2000, 60(4): 463-467. https://doi.org/10.1002/(SICI)1096-9071(200004)60:4<463::AID-JMV15>3.0.CO;2-M
- Martin P. KB Laupland, EH Frost, L. Valiquette. Laboratory diagnosis of Ebola virus disease. Intensive Care Medicine. 2015, 1-4.
- Oestereich L, A Ludtke, S Wurr, T Rieger, C Munoz-Fontela, S. Gunther. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Research. 2014, 105: 17-21. https://doi.org/10.1016/j.antiviral.2014.02.014
- World Health Organization. Viral haemorrhagic fever in imported monkeys. Wkly Epidemiol Rec.1992, 67(142): 20849-26003.
- World Health Organization. Ebola virus disease. Fact sheet No. 103, updated September 2014.
- World Health Organization. Ebola situation report. WHO Geneva, MAY. 2015.
- Qiu X, G Wong, J Audet, A Bello, L Fernando, JB Alimonti, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014, doi:10.1038/nature13777.
- Saez AM, S Weiss, K Nowak, V Lapeyre, F Zimmermann, A Dux, et al.. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Molecular Medicine. 2015, 7(1): 17-23. https://doi.org/10.15252/emmm.201404792
- Schieffelin JS, JG Shaffer, A Goba, M Gbakie, SK Gire, A Colubri, et al. Clinical illness and outcomes in patients with Ebola in Sierra Leone. New England Journal of Medicine. 2014, 371(22):2092-2100. https://doi.org/10.1056/NEJMoa1411680
- Smither SJ, LS Eastaugh, JA Steward, M Nelson, RP Lenk, M. S. Lever. Post-exposure efficacy of oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model. Antiviral Research. 2014, 104: 153-155. https://doi.org/10.1016/j.antiviral.2014.01.012
- Towner JS, TK Sealy, ML Khristova, CG. Albarino, S Conlan, SA Reeder, et al. Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathogens. 2008, 4(11): e1000212. https://doi.org/10.1371/journal.ppat.1000212
- Volchkov VE, H Feldmann, VA Volchkova, HD Klenk. Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proceedings of the National Academy of Sciences. 1998, 95(10): 5762-5767. https://doi.org/10.1073/pnas.95.10.5762
- Volchkov VE, VA Volchkova, E Muhlberger, LV Kolesnikova, M Weik, O Dolnik et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science. 2001, 291(5510): 1965-1969. https://doi.org/10.1126/science.1057269
- West TE, A von Saint Andre-von Arnim. Clinical Presentation and Management of Severe Ebola Virus Disease. Annals of the American Thoracic Society. 2014, 11(9): 1341-1350. https://doi.org/10.1513/AnnalsATS.201410-481PS
- Zaki SR, WJ Shieh, PW Greer, CS Goldsmith, T Ferebee, J Katshitshi, et al.. A novel immunohistochemical assay for the detection of Ebola virus in skin: implications for diagnosis, spread, and surveillance of Ebola hemorrhagic fever. Journal of Infectious Diseases. 1999, 179(Supplement 1): S36-S47. https://doi.org/10.1086/514319